Due to the progress of therapeutic technologies, cancer
is now possible to cure if it could be detected earlier.
However, a breakthrough is still needed for the early-diagnosis
because there are still considerable cases where the early
diagnosis is unsuccessful.
Cancer cells produce various proteins for its own proliferation
When normal cells are attacked by cancer cells, the specific
proteins are produced. Some of these proteins are decomposed
to peptides that are released into bloodstream. These proteins
and peptides can be the sign, or the "Marker"
to decide if the person has cancer cells at an early stage.
Link Genomics has founded the Research Centre for Proteome
Analysis to establish the analytical technology of microproteins
We now possess the technology that enables us to perform
microanalysis with high sensitivity.
We can say our "Early Diagnostic Markers of Cancer"
is on the way to fulfillment.